- Associated Press - Friday, February 28, 2014

ALBANY, N.Y. (AP) - A national long-term care pharmacy accused of accepting kickbacks from a drug manufacturer has agreed to a settlement of more than $4 million, with New York getting a share of the money.

Attorney General Eric Schneiderman says Kentucky-based Omnicare is settling allegations it requested price concessions from the drug manufacturer Amgen to switch patients suffering from chronic kidney disease and the effects of chemotherapy to Aranesp, an Amgen product.

New York’s Medicaid program will be reimbursed more than $664,000 from the settlement, which covers 48 states and the District of Columbia.

An Omnicare spokesman says Friday the company agreed to the settlement to avoid further litigation. It continues to deny any wrongdoing.

Schneiderman’s office says Amgen agreed last year to pay $24.9 million in a national settlement of the claims.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide